Search Results - "Abouda, G"

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease by Kahal, H., Abouda, G., Rigby, A. S., Coady, A. M., Kilpatrick, E. S., Atkin, S. L.

“…Summary Introduction Nonalcoholic fatty liver disease (NAFLD) has been linked to polycystic ovary syndrome (PCOS) and carries an increased risk of liver…”
Get full text

The Impact of Socio-Economic Deprivation on Management and Outcomes of Hepatocellular Carcinoma in East Yorkshire by Mohammed, M.S, Ferrier, G, Abouda, G, Corless, L

Get full text

The COMMANDS study: improving community-based diagnosis and management of non-alcoholic fatty liver disease by Burke, L, Williams, B, Mann, V, Wong, L.L, Corless, L, Abouda, G

Get full text

G01 : Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, doubleblinded, randomised, placebo-controlled phase II trial by Armstrong, M.J, Gaunt, P, Aithal, G.P, Parker, R, Barton, D, Hull, D, Guo, K, Abouda, G, Aldersley, M, Gough, S.C, Tomlinson, J.W, Brown, R.M, Hübscher, S.G, Newsome, P.N

Get full text

A case of recurrent variceal bleeding in a non-cirrhotic patient by Hutchinson, J.M., Patel, J.V., Abouda, G., Davies, M.H., Jones, R.L.

Get full text

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening by Ratziu, Vlad, Harrison, Stephen, Francque, Sven, Bedossa, Pierre, Lehert, Philippe, Serfaty, Lawrence, Romero-Gomez, Manuel, Boursier, Jérôme, Abdelmalek, Manal, Caldwell, Steve, Drenth, Joost, Anstee, Quentin, Hum, Dean, Hanf, Remy, Roudot, Alice, Megnien, Sophie, Staels, Bart, Sanyal, Arun

“…Background & Aims Elafibranor is an agonist of the peroxisome proliferator−activated receptor-α and peroxisome proliferator−activated receptor-δ. Elafibranor…”
Get full text

FRI-444 - The Community based management of NAFLD Study (COMMANDS): Improved diagnosis and referral using a novel integrated care pathway by Burke, L., Williams, B., Abouda, G., Corless, L.

Get full text

The Community based management of NAFLD Study (COMMANDS): Improved diagnosis and referral using a novel integrated care pathway by Burke, L., Williams, B., Abouda, G., Corless, L.

Get full text

THU-074 - The Impact of Socio-Economic Deprivation on Management and Outcomes of Hepatocellular Carcinoma in East Yorkshire by Mohammed, M.S., Ferrier, G., Abouda, G., Corless, L.

Get full text

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome by Javed, Zeeshan, Papageorgiou, Maria, Deshmukh, Harshal, Kilpatrick, Eric S, Mann, Vincent, Corless, Lynsey, Abouda, George, Rigby, Alan S, Atkin, Stephen L, Sathyapalan, Thozhukat

“…Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome and non-alcoholic-fatty-liver disease (NAFLD). Vitamin D supplementation may exert…”
Get full text

FRI-326 - The COMMANDS study: improving community-based diagnosis and management of non-alcoholic fatty liver disease by Burke, L., Williams, B., Mann, V., Wong, L.L., Corless, L., Abouda, G.

Get full text

Barrett's oesophagus in young adults: no increase in the putative Barrett's precursor, "multilayered epithelium"; raised lamina propria eosinophils identified by Tiam, R, Abouda, G, Dillon, J, Walsh, S.V

Get full text